NewCelase®GMPForAdiposeStemCellIsolation
Worthingtonnowoffersanotherpotentialsolutionforyouradiposestemcellisolationapplications;Celase®GMP,anavianandmammaliantissue-freeCollagenaseandneutralproteaseenzymeblendproducedunderGMPqualityconditionsbyCytoriTherapeutics,aleaderinthedevelopmentofhumanadiposestemcellisolationtherapiesforclinicalapplications.
Celase®GMPisspecificallydesignedforstemcellisolationfromhumanandotheradiposetissuewithfollowingadvantages:
•Asingle,sterile,ready-to-usevialcontainingbothcollagenaseandneutralproteasecandigestupto280g ofadiposetissuewithbest-in-classGMPqualityandshelflifeofupto72months.
•CurrentlyincludedinIDEapplicationsapprovedbytheU.S.FDAforalopecia,chronicheartfailure,hamstringinjuries,osteoarthritisoftheknee,andhandmanifestationsofscleroderma.
•ATechnicalDossierisavailablefromCytoritoeasethetransitionfromresearchtoclinicalapplications.
•ResearchprotocolsareavailablefromWorthingtonandCytorifordissociatingcanine,equine,human,ovine,porcine,rabbitandrodentadiposetissue.
•Aproprietary,blendedproteolyticenzymedesignedforefficient,gentleandreproducibleinvitrodissociationofnucleatedcellsfromadiposetissue.
•Producedusingavianandmammaliantissue-freerawmaterials,asepticprocessesandsterilefiltrationunder GMPguidelinestoassurethelowestlevelsofimpuritiesandstringentqualitystandards.